Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts.
about
GLO1 overexpression in human malignant melanomaCirculating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and agingClick chemistry in complex mixtures: bioorthogonal bioconjugationRole of methylglyoxal in Alzheimer's diseaseIsoflurane's Effect on Protein Conformation as a Proposed Mechanism for PreconditioningChemical Reactivity and Respiratory Toxicity of the α-Diketone Flavoring Agents: 2,3-Butanedione, 2,3-Pentanedione and 2,3-HexanedioneOsmotic stress is accompanied by protein glycation in Arabidopsis thalianaMethylglyoxal modifies heat shock protein 27 in glomerular mesangial cells.Beneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanismsProbing protein structure by amino acid-specific covalent labeling and mass spectrometry.Rapid Myoglobin Aggregation through Glucosamine-Induced α-Dicarbonyl Formation.Impaired Chaperone Activity of Human Heat Shock Protein Hsp27 Site-Specifically Modified with Argpyrimidine.Glycation in Demetalated Superoxide Dismutase 1 Prevents Amyloid Aggregation and Produces Cytotoxic Ages Adducts.Global Proteomic Analysis of Advanced Glycation End Products in the Arabidopsis Proteome Provides Evidence for Age-related Glycation Hotspots.3-hydroxykynurenine-mediated modification of human lens proteins: structure determination of a major modification using a monoclonal antibody.Critical role of methylglyoxal and AGE in mycobacteria-induced macrophage apoptosis and activation.Plasma levels of advanced glycation endproducts are associated with type 1 diabetes and coronary artery calcification.Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stressDifferential response to α-oxoaldehydes in tamoxifen resistant MCF-7 breast cancer cells.A Perspective on Reagent Diversity and Non-covalent Binding of Reactive Carbonyl Species (RCS) and Effector Reagents in Non-enzymatic Glycation (NEG): Mechanistic Considerations and Implications for Future Research.Tumor necrosis factor-induced modulation of glyoxalase I activities through phosphorylation by PKA results in cell death and is accompanied by the formation of a specific methylglyoxal-derived AGE3-nitropropionic acid is a suicide inhibitor of mitochondrial respiration that, upon oxidation by complex II, forms a covalent adduct with a catalytic base arginine in the active site of the enzymeTriple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypesRole for glyoxalase I in Alzheimer's disease.Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy.Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation.Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function.Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathyIdentification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins.Stereospecific synthesis and characterization of oligodeoxyribonucleotides containing an N2-(1-carboxyethyl)-2'-deoxyguanosine.Influence of nonenzymatic posttranslational modifications on constitution, oligomerization and receptor binding of S100A12Structural variation in bacterial glyoxalase I enzymes: investigation of the metalloenzyme glyoxalase I from Clostridium acetobutylicum.3-Deoxyglucosone: a potential glycating agent accountable for structural alteration in H3 histone protein through generation of different AGEs.Dietary advanced glycation end products and aging.Arg354 in the catalytic centre of bovine liver catalase is protected from methylglyoxal-mediated glycation.Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.Extract of Rhizoma Polygonum cuspidatum reduces early renal podocyte injury in streptozotocin‑induced diabetic rats and its active compound emodin inhibits methylglyoxal‑mediated glycation of proteins.The anti-tumor effects of calorie restriction are correlated with reduced oxidative stress in ENU-induced gliomas.Carbonylation induces heterogeneity in cardiac ryanodine receptor function in diabetes mellitus.Emerging drugs for diabetic nephropathy.
P2860
Q24630049-E7815595-CC2D-4B38-A0ED-D83F2C831767Q24650528-975F2C53-12B8-4784-B21D-CEDFEA800B1DQ26828895-7BC1FDDC-49D3-4647-8A04-7706906448F5Q27004644-60447125-2C06-4B30-A826-B5E498C6228BQ28740459-3751C22B-F1EC-4E9D-854A-1B8BB65D264DQ29248838-D9FC2E35-CF8D-441D-9741-180D49C7E057Q30313686-FD3A5F0C-9FC6-4A00-8040-1775DB75D1D3Q30333452-C869EAC4-51B6-4AE2-99B0-8C45DCAE2649Q30360076-541FA9A9-F93A-41CE-9CD1-80ED30E84CD8Q30373368-2B2F60C3-549E-4CF0-A538-73206C7CC76EQ30379535-5503ED6A-1D9C-4C13-9970-37583B04B399Q30390809-F23E7B28-8627-4B42-8FB0-360B0FCCF5A6Q30393668-C2743FCF-F9BC-4D52-B96A-4F32615CFC1EQ30403010-8F8A8C06-D74E-4FA1-9260-799292FA00D1Q30986731-83E4BC4E-77E7-4B66-8AB9-DE07D962DCE0Q33267290-0EBCFA0E-43DA-421F-8AC9-04A9F97F501CQ33589073-FC2051A4-D6AB-4475-B2D2-07DA3DE04AE7Q33773237-AEAB4EA2-493B-482A-A55E-D0F19C4BBEF4Q33831129-381C5743-8CBA-458C-AEF4-C3CAC1345269Q33854460-F4A4A99E-DD09-42DD-AF90-67FCA23DB9FBQ33894738-BB5523C6-C9A2-4C66-B994-2D26DEAB4DFFQ33992451-995A2315-8210-4D69-B46E-64C623AF13B7Q34221728-6B339F71-603B-48A1-BE00-8C1F74A31137Q34336935-E3513CD7-13B5-4E7E-8D7F-7A5FED2B6BEDQ34336978-45E5F711-ECFA-4081-B153-6E9AB7F60A24Q34350918-8C5CEBC2-3A02-4F03-8D1E-61B4DF6BFF8DQ34355343-C978D23D-8E92-4F0C-A249-A2EE00CC6269Q34388076-8DC508C5-90D4-4AB9-9A26-400D849A3E1BQ34528130-42C90EBA-912C-44F4-A2CE-48331E791E35Q35205169-29D8E7EE-F06E-4875-A3B0-13E3DFF49663Q35451921-A8DB0839-CC6A-4503-9AB9-E9531169A88BQ35516038-053453E0-6167-49C6-979D-F83253FD7E7FQ35562725-45E88C52-9BC6-48E7-9244-4DEDD498E1DBQ35670859-48E54F01-259E-4E72-9EC4-7B4ACD229A47Q35881127-AFD0E9AF-293E-47BC-BDC2-E5EC4D9006E1Q35896615-F7A71F17-7C56-4910-A8C8-CB0B7E1E8A13Q36089679-64CF56C4-8E6B-4C5F-9160-A480B8B37EE7Q36159690-95832AA8-E4BB-4773-AA68-E1F6A0F67386Q36174773-60AEDB03-4E0F-4D24-B0CA-BAE3AB13DA63Q36302838-9C99F9E4-A11F-43D9-8DD9-2FF15186348E
P2860
Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Methylglyoxal modification of ...... ethylglyoxal-arginine adducts.
@ast
Methylglyoxal modification of ...... ethylglyoxal-arginine adducts.
@en
type
label
Methylglyoxal modification of ...... ethylglyoxal-arginine adducts.
@ast
Methylglyoxal modification of ...... ethylglyoxal-arginine adducts.
@en
prefLabel
Methylglyoxal modification of ...... ethylglyoxal-arginine adducts.
@ast
Methylglyoxal modification of ...... ethylglyoxal-arginine adducts.
@en
P2093
P2860
P356
P1476
Methylglyoxal modification of ...... ethylglyoxal-arginine adducts.
@en
P2093
P2860
P304
18492-18502
P356
10.1074/JBC.274.26.18492
P407
P577
1999-06-01T00:00:00Z